Intervention Review

You have free access to this content

Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis

  1. Ian J Saldanha1,*,
  2. Oluwaseun Akinyede2,
  3. Karen A Robinson2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 9 DEC 2013

Assessed as up-to-date: 27 NOV 2013

DOI: 10.1002/14651858.CD009421.pub2


How to Cite

Saldanha IJ, Akinyede O, Robinson KA. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD009421. DOI: 10.1002/14651858.CD009421.pub2.

Author Information

  1. 1

    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, USA

  2. 2

    Johns Hopkins University, Department of Medicine, Baltimore, MD, USA

*Ian J Saldanha, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Room E6014, Baltimore, MD, 21204, USA. isaldan1@jhmi.edu.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 9 DEC 2013

SEARCH

References

References to studies excluded from this review

  1. References to studies excluded from this review
  2. Additional references
Bhorade 2011 {published and unpublished data}
  • Bhorade S, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, et al. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation. American Journal of Respiratory and Critical Care Medicine 2011;183(3):379-87. [PUBMED: 20833822]
  • Ghassemieh B, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, et al. Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation. The Journal of Heart and Lung Transplantation: the official publication of the International Society for Heart Transplantation 2013;32(7):701-6. [PUBMED: 23664526]
Iacono 2006 {published data only (unpublished sought but not used)}
  • Groves S,  Galazka M, Johnson B, Corcoran T, Verceles A, Britt E, et al. Inhaled cyclosporine and pulmonary function in lung transplant recipients. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010;23(1):31-9.
  • Iacono AT, Johnson BA, Grgurich WF, Corcoran TE, Youssef G, Smith-Seiler DA, et al. A randomized trial of inhalational cyclosporine in lung transplant recipients [abstract]. Pediatric Pulmonology 2004;38 Suppl 27:318. [CFGD Register: CO37; MEDLINE: 96204950]
  • Iacono AT, Johnson BA, Grgurich WF, Youssef JG, Corcoran TE, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. New England Journal of Medicine 2006;354(2):141-50.

Additional references

  1. References to studies excluded from this review
  2. Additional references
Aurora 2009
  • Aurora P, Edwards LB, Christie JD, Dobbels F, Kirk R, Rahmel AO, et al. Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Lung and Heart/LungTransplantation Report—2009. Journal of Heart and Lung Transplantation 2009;28(10):1023-30.
Christie 2011
  • Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth adult lung and heart-lung transplant report--2011. The Journal of Heart and Lung Transplantation: the official publication of the International Society for Heart Transplantation 2011;30(10):1104-22. [PUBMED: 21962018]
Cosimi 1981
Cystic Fibrosis Foundation 2011
  • Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2011. Cystic Fibrosis Foundation 2011.
Cystic Fibrosis Foundation 2013
  • Cystic Fibrosis Foundation. About Cystic Fibrosis: What you need to know. http://www.cff.org/AboutCF/ Last accessed October 14, 2013 2013.
Gee 2000
  • Gee L, Abbott J, Conway S, Etherington C, Webb A. Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax 2000;55(11):946-54.
Higgins 2003
Higgins 2011a
  • Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2009. Available from www.cochrane-handbook.org.
Higgins 2011b
  • Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2009. Available from www.cochrane-handbook.org.
Higgins 2011c
  • Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2009. Available from www.cochrane-handbook.org.
Hopkins 2002
  • Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. Journal of Heart and Lung Transplantation 2002;21(10):1062-7.
Hopkins 2008
ISHLT 2013
  • International Society for Heart and Lung Transplantation. Registries - Heart/Lung Registries. http://www.ishlt.org/registries/heartLungRegistry.asp (accessed 14 October 2013).
Izquierdo 2000
Jaramillo 2005
King-Biggs 1997
Kirkham 2010
  • Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, Williamson PR. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340(c365):637-40.
Knoop 2003
  • Knoop C, Haverich A, Fischer S. Immunosuppressive therapy after human lung transplantation. European Respiratory Monthly 2003;26:105-29.
Leonard 2001
  • Leonard MB, Szezech LA, Feldman HI. Design and Interpretation of Clinical Trials in Transplantation. In: Norman DJ, Turka LA editor(s). Primer on Transplantation. 2nd Edition. American Society of Transplantation, 2001:114-24.
Lischke 2007
  • Lischke R, Simonek J, Davidová R, Schützner J, Stolz AJ, Vojácek J, et al. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin. Transplantation Proceedings 2007;39(1):205-12.
Nathan 2007
National Cancer Institute 2010
  • National Cancer Institute. Dictionary of Cancer Terms. http://www.cancer.gov/dictionary/?CdrID=45728. National Cancer Institute of the US National Institutes of Health, (accessed 03 December 2010).
OPTN 2009
  • U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008. U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD.
Paradis 1993
  • Paradis I, Yousem S, Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clinics in Chest Medicine 1993;14(4):751-63.
Penninga 2013
  • Penninga L, Penninga EI, Møller CH, Iversen M, Steinbrüchel DA, Gluud C. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2013, issue 5. [DOI: 10.1002/14651858.CD008817.pub2]
Quittner 2009
  • Quittner AL, Modi AC, Wainwright C, Otto K, Kirihara J, Montgomery AB. Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest 2009;135(6):1610-8.
Ramsey 1996
Ratjen 2003
RevMan 2012
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rowe 2005
Wierda 2005
Yusen 2010